AI in Healthcare

The latest on artificial intelligence transforming medicine

News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.

Filtered by: noninvasive testingClear filter
industryPandaily

Alibaba DAMO Unveils an AI Model for Noninvasive Colorectal Cancer Screening

Pandaily reports that Alibaba DAMO Academy has introduced an AI model aimed at noninvasive colorectal cancer screening. The announcement adds to a growing wave of cancer-detection tools that seek to reduce dependence on invasive procedures and expand access to earlier diagnosis.

colorectal cancerscreeningAlibabanoninvasive testing
clinical

Breath Diagnostics Wins FDA Breakthrough Designation for OneBreath Platform

Breath Diagnostics received FDA Breakthrough Device designation for its OneBreath platform, a sign that regulators see promise in the technology’s clinical potential. The designation could help accelerate development for a platform that aims to make breath-based diagnostics more practical.

Medical Product Outsourcing
FDAbreakthrough designationdiagnostics
research

Noninvasive Colon Cancer Testing Gets a New AI Twist With Stool-Sample Approach

Researchers are reporting a noninvasive colon cancer test that uses AI and stool samples, pointing to another attempt to make screening easier and more accessible. If successful, the approach could expand participation in colorectal screening by lowering the barriers associated with colonoscopy.

The Eastleigh Voice
colon cancerAIstool sample
industry

Noninvasive Cancer Diagnostics Market Grows as AI and Liquid Biopsy Converge

Market coverage suggests noninvasive cancer diagnostics are moving from niche promise toward a broader commercial category. The strongest momentum appears to be in AI-enabled interpretation, liquid biopsy, and screening tools that can reduce dependence on invasive procedures.

GlobeNewswire
cancer diagnosticsnoninvasive testingliquid biopsy
clinical

BioAffinity Lung Cancer Test Heads to Cleveland Clinic Agenda

BioAffinity’s lung cancer test reaching the Cleveland Clinic agenda is a meaningful step because it suggests clinical stakeholders are willing to evaluate newer noninvasive tools. The case reflects growing momentum for tests that can complement or reduce reliance on traditional diagnostic pathways.

Stock Titan
lung cancerdiagnosticsCleveland Clinic

How this works

Discover

An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.

Structure

The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.

Publish

Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.